PubMed · 8107858
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
B Smith, L Böhm. 1994-02-24. Cyclotron future.. https://doi.org/10.1038/367676b0
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
A new arrangement consisting of two separate Fourier transform ion cyclotron resonance (FTICR) ion traps was used to develop methods for the manipulation of the ions produced by an electrospray ionization source (ESI). A first, "accumulation" trap, is generally maintained at a higher pressure than the second, high-performance "analyzer" trap. The manipulations developed and demonstrated include the following: (1) mass-selective ion transfers between the traps; (2) mass-selective step-wise accumulation of low-abundance ions of different mass-to-charge ratios transferred from the first trap to the analyzer trap; (3) simultaneous detection of ions in the analyzer trap and ion accumulation in the source trap; (4) simultaneous ion detection in the accumulation trap and ion storage in the analyzer trap; (5) sequential multiple transfers of the ions into the analyzer trap from the same ion population stored in the accumulation trap; (6) collision-induced dissociation of ions stored in the accumulation trap followed by mass-selective transfer of the product ions into the analyzer trap; (7) sequential transfer of the ions of different mass-to-charge ratios into the analyzer trap from the same ion population stored in the accumulation trap followed by the collision-induced dissociation of transferred ions in the analyzer trap. These ion manipulations benefit multistage studies and are projected to be useful in many biochemical applications of ESI-FTICR, including structural determination of biopolymers and study of noncovalent complexes.
A biomedical cyclotron facility primarily dedicated to radionuclide production has been extended by the addition of an experimental fast-neutron source for radiobiological and biophysical studies. Several beams of fast-neutrons with different average energies and LET distributions can now be provided. The neutrons are produced by bombarding berryllium targets with 18-32 McV protons or 8.7-15 MeV deuterons from our K = 32 negative-ion cyclotron. Average neutron energies range from approximately 4 to 15 MeV. Doses at maximum build-up vary from 0.24 to 1.85 cGy microA-1 min-1 at 1 m SSD, i.e. approximately 55 cGy min-1 at 30 microA of proton current at maximum energy. The design of the facility and some dosimetric results are presented.
The sources of the induced activity from the d(48.5)+Be fast neutron therapy beam of the Harper Hospital superconducting cyclotron have been investigated. The distribution of activity in the treatment room was measured, and the levels of dose equivalent to the staff were established. Activation spectra were measured with a high purity RE-Ge detector. Peaks corresponding to 28Al, 56Mn, 24Na, 64Cu, 66Cu, and 187W were present in the spectra. The dose equivalents due to the induced activation were measured by means of an ionization chamber type survey meter at six locations in the room. Irradiations of 120 monitor units were given at 15-min intervals, thus simulating the clinical situation. The measurements were made between the irradiations. The highest levels were registered around the treatment head. Two patterns are clearly distinguishable in these measurements. A fast decaying component with approximately 2 min half-life can be ascribed predominantly to 28Al and a slow growing component reaching saturation after about 4-5 treatments is associated with the presence of 56Mn. For uniform treatment load the activation build-up in each location was similar every day of the week with minimal values measured after the week end shut down. Personnel monitoring is achieved with dosimeters capable of detecting an extended range of neutron energies as well as beta rays and photons. Correlation between the number of fields treated and the doses to the radiation therapy technologists was shown. The mean dose equivalent received by the therapists is 7.1 +/- 0.2 microSv per treatment field. Means of reducing personnel dose equivalent levels are proposed.